Mutual Fund Details
NAV
₹340.2220
as on 27 Jun 2025, 09:00 PM
₹1.9604(0.58%)
Last Change
Scheme Ratings
5
rated by Value Research
Pharma
Rankings based on | as on Invalid date
×
Download the Paytm Money app now!
Invest in Stocks, F&O, Mutual Funds, IPOs, NFOS and Bonds.
Zero brokerage for 30 days- Zero account opening fees
- Zero AMC for life
Scan QR code to download the app
Investment Performance
would have given a return of
₹1,10,871
₹1,21,647
₹2,13,637
₹2,20,548
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
₹1,20,548
Profit (absolute return)
120.55%
in the last
1m
3m
1y
3y
5y
max
+1% Higher Returns
With Direct Plans on Paytm MoneyInvestment Returns
In the last 3 months
4.47%
In the last 6 months
0.33%
In the last 1 year
21.91%
In the last 3 years
120.55%
In the last 5 years
207.33%
In the last 10 years
245.34%
Absolute Returns
CAGR
Scheme Riskometer
low
low to moderate
moderate
moderately high
high
very high
Investors understand that their principal will be at very high risk
Scheme Information
SBI Healthcare Opportunities Fund Direct Plan-IDCW
as of 31 May 2025, 05:30 AM
₹3,689.28 Cr
Scheme Asset Size
Fund Type
Open-End
Exit Load
Exit load of 0.50% if redeemed within 15 days
0.89%
Expense Ratio
Plan
Dividend
Benchmark
BSE Healthcare Total Return Index
Exit Load
Exit load of 0.50% if redeemed within 15 days
Scheme Document
Sectors Holding in this Mutual Fund
as on 31 May 2025
Healthcare
93.26%
₹3,440.63 Cr
Chemicals
2.83%
₹104.41 Cr
Others
3.91%
₹144.25 Cr
Companies Holding in this Mutual Fund
as on 31 May 2025
Sun Pharmaceutical Industries Ltd.
13.78%
₹508.38 Cr
Max Healthcare Institute Ltd.
7.67%
₹282.97 Cr
Divi's Laboratories Ltd.
6.66%
₹245.71 Cr
Cipla Ltd.
6.65%
₹245.34 Cr
Lonza Group Ag
4.94%
₹182.25 Cr
Others
60.30%
₹2,224.64 Cr
View All
View All
Companies Holding in this Mutual Fund
as on 31 May 2025
Sun Pharmaceutical Industries Ltd.
13.78%
₹508.38 Cr
Max Healthcare Institute Ltd.
7.67%
₹282.97 Cr
Divi's Laboratories Ltd.
6.66%
₹245.71 Cr
Cipla Ltd.
6.65%
₹245.34 Cr
Lonza Group Ag
4.94%
₹182.25 Cr
Others
60.30%
₹2,224.64 Cr
View All
View All
This fund's returns:
30.14%Return Duration
3 Years
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth
EquityPharma
Min. Investment
₹100
Category Returns
19.72%
30.54%
3Y Returns
30.54
SBI Healthcare Opportunities Fund Direct Plan-Growth
EquityPharma
Min. Investment
₹500
Category Returns
19.72%
30.54%
3Y Returns
30.14
UTI Healthcare Fund Direct-Growth
EquityPharma
Min. Investment
₹500
Category Returns
19.72%
30.54%
3Y Returns
27.60
About SBI Healthcare Opportunities Fund Direct Plan-IDCW
SBI Healthcare Opportunities Fund Direct Plan-IDCW is a Equity mutual fund scheme from SBI Mutual Fund. This scheme was launched on Invalid date. It has an AUM of ₹3,689.28 Crores and the latest NAV decalared is ₹340.222 as on 01 Jul 2025 at 2:17 am.
SBI Healthcare Opportunities Fund Direct Plan-IDCW scheme return performance in last 1 year is 21.91%, in last 3 years is 120.55% and 710.29% since scheme launch. The min. SIP amount to invest in this scheme is ₹500.
Scheme Details
| AUM: | ₹3,689.28 Cr |
| Category: | Equity: Sectoral-Pharma |
| Launch Date: | Invalid date |
| Fund Type: | Open-End |
AMC Information
SBI Mutual Fund
View AMC Details
₹11,46,619.54 Cr
AUM
189
Schemes
Address
9th Floor-Crescenzo, C-38 & 39-G Block, Bandra-Kurla Complex,Bandra (East)400051
Phone Number
Phone : 022-61793000 / 1800-425-5425
Fax : 022-22189663
Email / Website
Start investing in minutes
Download app to Explore
Scan this QR code to download the app now!
Or download from
